EXPERIMENTAL & CLINICAL MEDICINE GEORGIA,
Journal Year:
2024,
Volume and Issue:
unknown
Published: June 21, 2024
The
human
microbiome,
comprising
trillions
of
bacteria,
fungi,
and
viruses,
profoundly
influences
both
our
organism
the
surrounding
environment.
Emerging
research
highlights
symbiotic
relationship
between
microbial
organisms,
suggesting
their
co-evolution
into
superorganisms.
Throughout
life,
gut
microbiome
undergoes
significant
shifts,
impacting
immune,
nervous,
cardiovascular
system
homeostasis.
Understanding
these
dynamics
offers
insights
personalized
medicine
therapeutic
interventions
targeting
dysbiosis.
Microorganisms,
Journal Year:
2024,
Volume and Issue:
12(1), P. 194 - 194
Published: Jan. 18, 2024
Probiotics
are
known
to
promote
human
health
either
precautionary
in
healthy
individuals
or
therapeutically
patients
suffering
from
certain
ailments.
Although
this
knowledge
was
empirical
past
tomes,
modern
science
has
already
verified
it
and
expanded
new
limits.
These
microorganisms
can
be
found
nature
various
foods
such
as
dairy
products
supplements
formulated
for
clinical
preventive
use.
The
current
review
examines
the
different
mechanisms
of
action
probiotic
strains
how
they
interact
with
organism
host.
Emphasis
is
put
on
therapeutic
use
these
beneficial
conditions
gastrointestinal
tract.
Diseases
tract
particularly
any
malfunction
inflammation
intestines
seriously
compromise
whole
organism.
interaction
between
host’s
microbiota
alleviate
signs
symptoms
while
some
cases,
due
course,
intervene
underlying
pathology.
Various
safety
issues
probiotics
also
discussed.
Biomedicine & Pharmacotherapy,
Journal Year:
2023,
Volume and Issue:
169, P. 115821 - 115821
Published: Nov. 10, 2023
Short-chain
fatty
acids
(SCFAs),
such
as
acetate,
propionate,
and
butyrate,
have
emerged
critical
mediators
in
the
communication
between
human
microbiota
its
host.
As
first
responder
to
inflammatory
site,
neutrophils
play
an
important
role
protecting
host
against
bacterial
infections.
Recent
investigations
revealed
that
SCFAs
generated
from
influence
various
neutrophil
activities,
including
activation,
migration,
generation
of
processes.
also
been
demonstrated
exhibit
potential
therapeutic
benefits
a
variety
disorders
related
dysfunction,
bowel
disease,
viral
infectious
disorders,
cancer.
This
study
aims
examine
molecular
processes
behind
complicated
link
neutrophils,
well
their
on
neutrophil-driven
disorders.
In
addition,
we
will
provide
in-depth
review
current
research
diagnostic
value
possible
biomarkers
for
neutrophil-related
diseases.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(19), P. 14822 - 14822
Published: Oct. 1, 2023
Coronavirus
disease
(COVID-19)
is
an
infection
caused
by
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
which
can
be
asymptomatic
or
present
with
multiple
organ
dysfunction.
Many
infected
individuals
have
chronic
alterations
associated
neuropsychiatric,
endocrine,
gastrointestinal,
and
musculoskeletal
symptoms,
even
several
months
after
onset,
developing
long-COVID
post-acute
COVID-19
(PACS).
Microbiota
dysbiosis
contributes
to
the
onset
progression
of
many
viral
diseases,
including
post-COVID-19
manifestations,
could
serve
as
potential
diagnostic
prognostic
biomarkers.
This
review
aimed
discuss
most
recent
findings
on
gut
microbiota
its
relationship
sequelae
PACS.
Elucidating
these
mechanisms
help
develop
personalized
non-invasive
clinical
strategies
identify
at
a
higher
risk
experiencing
complications
Moreover,
highlights
importance
targeting
composition
avoid
possible
prophylactic
therapeutic
measures
against
PACS
in
future
studies.
Frontiers in Nutrition,
Journal Year:
2025,
Volume and Issue:
11
Published: Jan. 8, 2025
Short-chain
fatty
acids
(SCFAs),
derived
from
the
fermentation
of
dietary
fiber
by
intestinal
commensal
bacteria,
have
demonstrated
protective
effects
against
acute
lung
injury
(ALI)
in
animal
models.
However,
findings
shown
variability
across
different
studies.
It
is
necessary
to
conduct
a
comprehensive
evaluation
efficacy
these
treatments
and
their
consistency.
This
systematic
review
meta-analysis
aimed
explore
SCFAs
on
ALI
based
preclinical
research
evidence,
order
provide
new
treatment
strategies
for
ALI.
We
included
studies
that
tested
study
was
performed
according
Preferred
Reporting
Items
Systematic
Reviews
Meta-Analyses
(PRISMA)
guidelines.
A
search
relevant
conducted
PubMed,
Embase,
Web
Science,
Cochrane
Library,
China
National
Knowledge
Infrastructure
(CNKI)
databases
up
February
2024.
The
data
were
extracted
accordance
with
established
selection
criteria,
risk
bias
evaluated
each
study.
total
16
articles
finally
meta-analysis.
results
indicated
significantly
reduced
wet-to-dry
weight
(SMD
=
-2.75,
95%
CI
-3.46
-2.03,
p
<
0.00001),
scores
-5.07,
-6.25
-3.89,
myeloperoxidase
-3.37,
-4.05
-2.70,
tumor
necrosis
factor-alpha
-3.31,
-4.45
-2.16,
0.00001)
malondialdehyde
-3.91,
-5.37
-2.44,
levels
models
subgroup
analysis
varies
dosage
duration
treatment.
can
reduce
inflammation
oxidative
stress
clinical
deserves
further
in-depth
research.
https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=584008,
CRD42024584008.
Journal of Agricultural and Food Chemistry,
Journal Year:
2025,
Volume and Issue:
73(9), P. 5194 - 5207
Published: Feb. 22, 2025
Fermented
vegetable
beverages
have
potential
beneficial
effects
on
the
health
associated
with
production
of
bioactive
flavonoids
and
lignans
by
selected
bacterial
strains.
Here,
we
studied
a
soy
beverage
fermented
Bifidobacterium
pseudocatenulatum
INIA
P815,
both
supplemented
lignan
extracts,
in
female
mouse
model
high-fat
diet
followed
for
16
weeks.
The
induced
an
increase
adipose
tissue
plasma
cholesterol
as
well
modified
fecal
microbiota.
Mice
groups
receiving
any
showed
reduction
mean
area
ovarian
fat
adipocytes
exhibited
tissues,
accompanied
higher
antioxidant
activity
plasma.
group
mice
subjected
to
also
demonstrated
lower
levels,
short-chain
fatty
acid
production,
levels
daidzein,
genistein,
enterolignans,
herbacetin
organs.
Moreover,
fertility
that
received
was
enhanced,
resulting
percentage
blastocysts
per
mouse.
Therefore,
consumption
B.
P815
could
be
favoring
ameliorating,
some
extent,
diet.
Nutrients,
Journal Year:
2025,
Volume and Issue:
17(6), P. 1068 - 1068
Published: March 19, 2025
The
issue
of
antibiotic-resistant
bacterial
infections,
coupled
with
the
rise
in
viral
pandemics
and
slow
development
new
antibacterial
antiviral
treatments,
underscores
critical
need
for
novel
strategies
to
mitigate
spread
drug-resistant
pathogens,
enhance
efficacy
existing
therapies,
accelerate
discovery
deployment
innovative
antimicrobial
solutions.
One
promising
approach
address
these
challenges
is
dietary
supplementation
non-digestible
oligosaccharides
(NDOs).
NDOs,
including
human
milk
(HMOs),
play
a
vital
role
shaping
sustaining
healthy
gut
microbiota.
Beyond
stimulating
growth
activity
beneficial
bacteria,
NDOs
can
also
interact
directly
pathogenic
bacteria
viruses.
Their
properties
arise
from
their
unique
interactions
pathogens
ability
modulate
host’s
immune
system.
function
as
decoy
receptors,
inhibit
pathogen
growth,
bind
toxins,
stimulate
host
response,
exhibit
anti-biofilm
properties,
barrier
protection.
However,
notable
gap
exists
comprehensive
assessment
vivo
clinical
data
on
this
topic.
This
review
aims
provide
an
in-depth
overview
evidence
related
effects
various
HMOs,
focus
discussing
possible
mechanisms
action.
Antibiotics,
Journal Year:
2025,
Volume and Issue:
14(4), P. 371 - 371
Published: April 3, 2025
The
human
gut
microbiota—an
intricate
and
dynamic
ecosystem—plays
a
pivotal
role
in
metabolic
regulation,
immune
modulation,
the
maintenance
of
intestinal
barrier
integrity.
Although
antibiotic
therapy
is
indispensable
for
managing
bacterial
infections,
it
profoundly
disrupts
microbial
communities.
Such
dysbiosis
typified
by
diminished
diversity
shifts
community
structure,
especially
among
beneficial
genera
(e.g.,
Bifidobacterium
Eubacterium),
fosters
antibiotic-resistant
strains
horizontal
transfer
resistance
genes.
These
alterations
compromise
colonization
resistance,
increase
permeability,
amplify
susceptibility
to
opportunistic
pathogens
like
Clostridioides
difficile.
Beyond
gastrointestinal
disorders,
emerging
evidence
associates
with
systemic
conditions,
including
chronic
inflammation,
syndrome,
neurodegenerative
diseases,
underscoring
relevance
microbiota–gut–brain
axis.
recovery
pre-existing
communities
post-antibiotic
highly
variable,
influenced
drug
spectrum,
dosage,
treatment
duration.
Innovative
interventions—such
as
fecal
microbiota
transplantation
(FMT),
probiotics,
synbiotics,
precision
microbiome
therapeutics—have
shown
promise
counteracting
mitigating
its
adverse
effects.
therapies
align
closely
stewardship
programs
aimed
at
minimizing
unnecessary
use
preserve
curtail
spread
multidrug-resistant
organisms.
This
review
emphasizes
pressing
need
microbiota-centered
strategies
optimize
administration,
promote
long-term
health
resilience,
alleviate
disease
burden
associated
antibiotic-induced
dysbiosis.